JP3905132B2 - Ｐｅｇ存在下でのカラムクロマトグラフィーを使用するプラスミドｄｎａの精製 - Google Patents
Ｐｅｇ存在下でのカラムクロマトグラフィーを使用するプラスミドｄｎａの精製 Download PDFInfo
- Publication number
- JP3905132B2 JP3905132B2 JP50813098A JP50813098A JP3905132B2 JP 3905132 B2 JP3905132 B2 JP 3905132B2 JP 50813098 A JP50813098 A JP 50813098A JP 50813098 A JP50813098 A JP 50813098A JP 3905132 B2 JP3905132 B2 JP 3905132B2
- Authority
- JP
- Japan
- Prior art keywords
- plasmid dna
- dna
- peg
- polyethylene glycol
- chromatography
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000013612 plasmid Substances 0.000 title claims abstract description 95
- 238000004440 column chromatography Methods 0.000 title abstract description 14
- 238000000746 purification Methods 0.000 title abstract description 10
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 50
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 50
- 238000000034 method Methods 0.000 claims abstract description 40
- 239000000872 buffer Substances 0.000 claims description 24
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 claims description 18
- 238000005571 anion exchange chromatography Methods 0.000 claims description 11
- 238000004587 chromatography analysis Methods 0.000 claims description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 10
- 239000012504 chromatography matrix Substances 0.000 claims description 10
- 230000000813 microbial effect Effects 0.000 claims description 8
- 239000006166 lysate Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 6
- 239000011159 matrix material Substances 0.000 claims description 4
- 239000005909 Kieselgur Substances 0.000 claims description 3
- 238000004255 ion exchange chromatography Methods 0.000 claims description 3
- 238000001042 affinity chromatography Methods 0.000 claims description 2
- 239000013592 cell lysate Substances 0.000 claims description 2
- 238000011098 chromatofocusing Methods 0.000 claims description 2
- 238000004191 hydrophobic interaction chromatography Methods 0.000 claims description 2
- 238000004366 reverse phase liquid chromatography Methods 0.000 claims description 2
- 239000003599 detergent Substances 0.000 claims 1
- 238000002270 exclusion chromatography Methods 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 14
- 239000003795 chemical substances by application Substances 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 238000002955 isolation Methods 0.000 abstract description 3
- 238000009833 condensation Methods 0.000 abstract 2
- 230000005494 condensation Effects 0.000 abstract 2
- 229960000074 biopharmaceutical Drugs 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 113
- 210000004027 cell Anatomy 0.000 description 23
- 108090000623 proteins and genes Proteins 0.000 description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
- 239000000523 sample Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 9
- 230000027455 binding Effects 0.000 description 9
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 8
- 239000000356 contaminant Substances 0.000 description 7
- 238000000855 fermentation Methods 0.000 description 7
- 230000004151 fermentation Effects 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 230000006037 cell lysis Effects 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 6
- 239000012535 impurity Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 229960005542 ethidium bromide Drugs 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 230000004931 aggregating effect Effects 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 238000005349 anion exchange Methods 0.000 description 3
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 3
- 239000012560 cell impurity Substances 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000008394 flocculating agent Substances 0.000 description 3
- 238000001415 gene therapy Methods 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010091938 HLA-B7 Antigen Proteins 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 238000011097 chromatography purification Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000000432 density-gradient centrifugation Methods 0.000 description 2
- 238000011026 diafiltration Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 238000001641 gel filtration chromatography Methods 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 238000001542 size-exclusion chromatography Methods 0.000 description 2
- 229940063673 spermidine Drugs 0.000 description 2
- -1 sterile fill Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 241000710188 Encephalomyocarditis virus Species 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 108091092566 Extrachromosomal DNA Proteins 0.000 description 1
- 101710120978 Kanamycin resistance protein Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101000729852 Pan troglodytes Beta-2-microglobulin Proteins 0.000 description 1
- 229920002145 PharMed Polymers 0.000 description 1
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 239000012614 Q-Sepharose Substances 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 238000010420 art technique Methods 0.000 description 1
- 108010006025 bovine growth hormone Proteins 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000003196 chaotropic effect Effects 0.000 description 1
- 238000011210 chromatographic step Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229920002523 polyethylene Glycol 1000 Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011027 product recovery Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 239000012146 running buffer Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/692,590 US5707812A (en) | 1996-08-06 | 1996-08-06 | Purification of plasmid DNA during column chromatography |
| US08/692,590 | 1996-08-06 | ||
| PCT/US1997/013647 WO1998005767A1 (en) | 1996-08-06 | 1997-08-05 | Purification of plasmid dna by peg-precipitation and column chromatography |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2000515385A JP2000515385A (ja) | 2000-11-21 |
| JP2000515385A5 JP2000515385A5 (enExample) | 2005-04-07 |
| JP3905132B2 true JP3905132B2 (ja) | 2007-04-18 |
Family
ID=24781207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50813098A Expired - Fee Related JP3905132B2 (ja) | 1996-08-06 | 1997-08-05 | Ｐｅｇ存在下でのカラムクロマトグラフィーを使用するプラスミドｄｎａの精製 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5707812A (enExample) |
| EP (1) | EP0920497B1 (enExample) |
| JP (1) | JP3905132B2 (enExample) |
| AT (1) | ATE287948T1 (enExample) |
| CA (1) | CA2262820C (enExample) |
| DE (1) | DE69732360T2 (enExample) |
| WO (1) | WO1998005767A1 (enExample) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7026468B2 (en) * | 1996-07-19 | 2006-04-11 | Valentis, Inc. | Process and equipment for plasmid purification |
| US7807822B2 (en) * | 1996-08-01 | 2010-10-05 | Robert Bridenbaugh | Methods for purifying nucleic acids |
| US20030125278A1 (en) * | 1997-08-13 | 2003-07-03 | Tang De-Chu C. | Immunization of animals by topical applications of a salmonella-based vector |
| US6348450B1 (en) | 1997-08-13 | 2002-02-19 | The Uab Research Foundation | Noninvasive genetic immunization, expression products therefrom and uses thereof |
| US20030045492A1 (en) * | 1997-08-13 | 2003-03-06 | Tang De-Chu C. | Vaccination by topical application of recombinant vectors |
| US6706693B1 (en) | 1997-08-13 | 2004-03-16 | The Uab Research Foundation | Vaccination by topical application of genetic vectors |
| US6716823B1 (en) | 1997-08-13 | 2004-04-06 | The Uab Research Foundation | Noninvasive genetic immunization, expression products therefrom, and uses thereof |
| US6111096A (en) | 1997-10-31 | 2000-08-29 | Bbi Bioseq, Inc. | Nucleic acid isolation and purification |
| US7626017B2 (en) * | 1997-10-31 | 2009-12-01 | Pressure Biosciences, Inc. | Pressure-enhanced extraction and purification |
| US6214586B1 (en) * | 1997-12-08 | 2001-04-10 | Genzyme Corporation | Method for purifying plasmid DNA and plasmid DNA substantially free of genomic DNA |
| EP0964057B1 (en) | 1998-05-11 | 2004-12-22 | Tosoh Corporation | Method for separating nucleic acids by means of liquid chromatography |
| US6534262B1 (en) | 1998-05-14 | 2003-03-18 | Whitehead Institute For Biomedical Research | Solid phase technique for selectively isolating nucleic acids |
| DE19916534A1 (de) * | 1999-04-13 | 2000-10-19 | Gsf Forschungszentrum Umwelt | RNA-Isolierungs-Kit |
| US20040009936A1 (en) * | 1999-05-03 | 2004-01-15 | Tang De-Chu C. | Vaccine and drug delivery by topical application of vectors and vector extracts |
| DK1187840T4 (da) | 1999-05-28 | 2013-02-04 | Lonza Biolog Inc | Fremgangsmåder til DNA-oprensning |
| US6617108B1 (en) | 1999-07-12 | 2003-09-09 | Technology Licensing Co. Llc | Methods and compositions for biotechnical separations using selective precipitation by compaction agents |
| US20020010145A1 (en) * | 1999-07-12 | 2002-01-24 | Willson Richard C. | Apparatus, methods and compositions for biotechnical separations |
| CA2378944A1 (en) | 1999-07-23 | 2001-02-01 | Genentech, Inc. | Method for rnase- and organic solvent-free plasmid dna purification using tangential flow filtration |
| US6281349B1 (en) | 1999-08-18 | 2001-08-28 | David E. Pulleyblank | Method for nucleic acid purification using iodine |
| US6464976B1 (en) | 1999-09-07 | 2002-10-15 | Canji, Inc. | Methods and compositions for reducing immune response |
| US20020012990A1 (en) * | 1999-12-22 | 2002-01-31 | Lander Russel Jackson | Process for the scaleable purification of plasmid DNA |
| DE10006591B4 (de) * | 2000-02-11 | 2007-03-29 | Eppendorf Ag | Verfahren zur Aufreinigung von Nukleinsäuren |
| PT102491B (pt) | 2000-07-10 | 2003-02-28 | Inst Superior Tecnico | Processo para producao e purificacao de dna plasmidico |
| US7074333B2 (en) * | 2001-01-19 | 2006-07-11 | Millipore Corporation | Recovery of linear nucleic acids by salt dilution and/or reduced pressure prior to continuous pressure differential ultrafiltration |
| DE10113815A1 (de) * | 2001-03-21 | 2002-10-02 | Eppendorf Ag | Verfahren zur Isolierung von Plasmiden oder Proteinen aus suspendierten Bakterien- oder Hefezellen |
| US6406892B1 (en) | 2001-05-23 | 2002-06-18 | Bio-Rad Laboratories, Inc. | Acetate-free purification of plasmid DNA on hydroxyapatite |
| US20030211970A1 (en) * | 2001-06-01 | 2003-11-13 | Samuel Nochumson | Processing of plasmid-containing fluids |
| KR100502473B1 (ko) * | 2001-11-08 | 2005-07-20 | 동아제약주식회사 | 플라스미드 ｄｎａ의 분리방법 |
| KR100463415B1 (ko) * | 2001-12-12 | 2004-12-23 | 씨제이 주식회사 | 세균내ｄｎａ 또는 ｒｎａ로부터 리포폴리사카라이드를제거하는 방법 |
| US6833238B2 (en) * | 2002-01-04 | 2004-12-21 | Applera Corporation | Petal-array support for use with microplates |
| US20040018559A1 (en) * | 2002-07-26 | 2004-01-29 | Applera Corporation | Size-exclusion ion-exchange particles |
| WO2004024283A2 (en) * | 2002-09-13 | 2004-03-25 | Valentis, Inc. | Apparatus and method for preparative scale purification of nucleic acids |
| JP4723254B2 (ja) * | 2002-12-23 | 2011-07-13 | バイカル インコーポレイテッド | プラスミドｄｎａを精製するための方法 |
| DK2364769T3 (en) | 2003-05-30 | 2016-04-11 | Vgxi Inc | Apparatus and methods for biomaterialeproduktion |
| US20050196856A1 (en) * | 2004-02-18 | 2005-09-08 | Applera Corporation | Polyelectrolyte-coated size-exclusion ion-exchange particles |
| US20060160122A1 (en) * | 2004-02-18 | 2006-07-20 | Applera Corporation | Polyelectrolyte-coated size-exclusion ion-exchange particles |
| US20050181378A1 (en) * | 2004-02-18 | 2005-08-18 | Applera Corporation | Polyelectrolyte-coated size-exclusion ion-exchange particles |
| US7504243B2 (en) | 2004-03-19 | 2009-03-17 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for the production of biliverdin |
| EP1776458A2 (en) | 2004-07-30 | 2007-04-25 | Agencourt Bioscience Corporation | Methods of isolating nucleic acids using multifunctional group-coated solid phase carriers |
| JP4971997B2 (ja) | 2005-01-31 | 2012-07-11 | メルク・シャープ・エンド・ドーム・コーポレイション | プラスミドｄｎａの精製方法 |
| CA2597482A1 (en) * | 2005-02-11 | 2006-08-17 | Invitrogen Dynal As | Method for isolating nucleic acids comprising the use of ethylene glycol multimers |
| KR20070120970A (ko) * | 2005-02-23 | 2007-12-26 | 유에이비 리서치 파운데이션 | 알킬-글리코시드로 증진된 예방접종 |
| CA2604909A1 (en) * | 2005-04-15 | 2006-10-26 | The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services | Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen |
| WO2007065025A2 (en) * | 2005-11-29 | 2007-06-07 | Wisconsin Alumni Research Foundation | Method of dna analysis using micro/nanochannel |
| GB2443505B (en) * | 2006-09-26 | 2008-12-31 | Ge Healthcare Bio Sciences | Nucleic acid purification method |
| GB2445442A (en) * | 2006-09-26 | 2008-07-09 | Ge Healthcare Bio Sciences | Nucleic acid purification using anion exchange |
| GB2445441B (en) * | 2006-09-26 | 2010-06-30 | Ge Healthcare Bio Sciences | Nucleic acid purification method |
| WO2008150826A1 (en) * | 2007-05-31 | 2008-12-11 | Ge Healthcare Uk Limited | Modified spin column for simple and rapid plasmid dna extraction |
| US8067580B2 (en) * | 2008-02-07 | 2011-11-29 | Ge Healthcare Bio-Sciences Corp. | Isolation of DNA, RNA and protein from a single sample |
| US20090227011A1 (en) * | 2008-02-29 | 2009-09-10 | Shizhong Chen | Methods of purifying plasmid dna |
| EP2906935B1 (en) | 2012-10-12 | 2018-04-04 | Sage Science, Inc. | Side-eluting molecular fractionator |
| JP6381628B2 (ja) | 2013-03-18 | 2018-08-29 | キアゲン ゲーエムベーハー | 生物試料の安定化 |
| CN107109487B (zh) | 2014-10-15 | 2022-03-04 | 赛琪科学股份有限公司 | 自动处理核酸和电泳样品制备的装置、方法和系统 |
| WO2016061556A1 (en) * | 2014-10-16 | 2016-04-21 | Sage Science, Inc. | Methods and systems for controlling the shear modulus of genomic length dsdna molecules |
| WO2017087979A1 (en) | 2015-11-20 | 2017-05-26 | Washington University | Preparative electrophoretic method for targeted purification of genomic dna fragments |
| WO2018187779A1 (en) | 2017-04-07 | 2018-10-11 | Sage Science, Inc. | Systems and methods for detection of genetic structural variation using integrated electrophoretic dna purification |
| CA3139679A1 (en) * | 2019-05-15 | 2020-11-19 | Translate Bio, Inc. | Methods for purification of messenger rna |
| CN115612684A (zh) * | 2022-11-01 | 2023-01-17 | 北京启辰生生物科技有限公司 | Gmp级质粒dna大规模简化生产方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01304886A (ja) * | 1988-05-31 | 1989-12-08 | Sekisui Chem Co Ltd | Ｄｎａの精製方法 |
| DE4321904B4 (de) * | 1993-07-01 | 2013-05-16 | Qiagen Gmbh | Verfahren zur chromatographischen Reinigung und Trennung von Nucleinsäuregemischen |
| US5561064A (en) * | 1994-02-01 | 1996-10-01 | Vical Incorporated | Production of pharmaceutical-grade plasmid DNA |
-
1996
- 1996-08-06 US US08/692,590 patent/US5707812A/en not_active Expired - Lifetime
-
1997
- 1997-08-05 CA CA002262820A patent/CA2262820C/en not_active Expired - Fee Related
- 1997-08-05 DE DE69732360T patent/DE69732360T2/de not_active Expired - Lifetime
- 1997-08-05 AT AT97936375T patent/ATE287948T1/de not_active IP Right Cessation
- 1997-08-05 JP JP50813098A patent/JP3905132B2/ja not_active Expired - Fee Related
- 1997-08-05 WO PCT/US1997/013647 patent/WO1998005767A1/en not_active Ceased
- 1997-08-05 EP EP97936375A patent/EP0920497B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2262820A1 (en) | 1998-02-12 |
| DE69732360T2 (de) | 2006-04-06 |
| JP2000515385A (ja) | 2000-11-21 |
| EP0920497A1 (en) | 1999-06-09 |
| DE69732360D1 (de) | 2005-03-03 |
| CA2262820C (en) | 2007-10-23 |
| EP0920497B1 (en) | 2005-01-26 |
| US5707812A (en) | 1998-01-13 |
| ATE287948T1 (de) | 2005-02-15 |
| WO1998005767A1 (en) | 1998-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3905132B2 (ja) | Ｐｅｇ存在下でのカラムクロマトグラフィーを使用するプラスミドｄｎａの精製 | |
| EP0268946B1 (en) | Method for separating long-chain nucleic acids | |
| US6383393B1 (en) | Chromatographic purification and separation process for mixtures of nucleic acids | |
| AU709003B2 (en) | A method for large scale plasmid purification | |
| US6177278B1 (en) | Nucleic acid purification and process | |
| US6197553B1 (en) | Method for large scale plasmid purification | |
| EP0988307B1 (en) | Solid-phase nucleic acid isolation | |
| US6410274B1 (en) | Plasmid DNA purification using divalent alkaline earth metal ions and two anion exchangers | |
| AU708798B2 (en) | A method for large scale plasmid purification | |
| HU225426B1 (en) | Method for purification of double stranded plasmid dna | |
| US20020015982A1 (en) | Method of purifying dna in a cross-flow centrifuge | |
| AU2002302045B2 (en) | Nucleic acid purification and process | |
| MXPA98007323A (en) | Purification of plasmid dna of pharmaceutical quality | |
| MXPA99006453A (en) | Method of purifying dna in a cross-flow centrifuge |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20040402 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20040422 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040729 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040729 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20061212 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070111 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110119 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110119 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120119 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130119 Year of fee payment: 6 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |